GT Biopharma, Inc. (GTBP)
0.3036
0.00 (0.00%)
USD |
NASDAQ |
Aug 25, 15:26
GT Biopharma Market Cap : 13.56M for Aug. 25, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 24, 2026 | 13.66M |
| August 21, 2026 | 12.89M |
| August 20, 2026 | 12.60M |
| August 19, 2026 | 12.82M |
| August 18, 2026 | 12.30M |
| August 17, 2026 | 12.73M |
| August 14, 2026 | 13.22M |
| August 13, 2026 | 13.28M |
| August 12, 2026 | 13.49M |
| August 11, 2026 | 13.97M |
| August 10, 2026 | 11.28M |
| August 07, 2026 | 11.26M |
| August 06, 2026 | 10.59M |
| August 05, 2026 | 11.17M |
| August 04, 2026 | 11.47M |
| August 03, 2026 | 10.86M |
| July 31, 2026 | 10.33M |
| July 30, 2026 | 10.83M |
| July 29, 2026 | 10.62M |
| July 28, 2026 | 11.14M |
| July 27, 2026 | 11.75M |
| July 24, 2026 | 11.41M |
| July 23, 2026 | 11.79M |
| July 22, 2026 | 12.16M |
| July 21, 2026 | 12.61M |
| Date | Value |
|---|---|
| July 20, 2026 | 12.00M |
| July 17, 2026 | 12.52M |
| July 16, 2026 | 13.49M |
| July 15, 2026 | 12.33M |
| July 14, 2026 | 12.98M |
| July 13, 2026 | 13.64M |
| July 10, 2026 | 14.95M |
| July 09, 2026 | 15.73M |
| July 08, 2026 | 16.45M |
| July 07, 2026 | 16.18M |
| July 06, 2026 | 17.23M |
| July 02, 2026 | 16.60M |
| July 01, 2026 | 17.38M |
| June 30, 2026 | 17.23M |
| June 29, 2026 | 15.48M |
| June 26, 2026 | 15.13M |
| June 25, 2026 | 14.64M |
| June 24, 2026 | 16.05M |
| June 23, 2026 | 17.37M |
| June 22, 2026 | 17.26M |
| June 18, 2026 | 18.08M |
| June 17, 2026 | 16.15M |
| June 16, 2026 | 15.68M |
| June 15, 2026 | 16.49M |
| June 12, 2026 | 15.73M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 5.269B |
| Alnylam Pharmaceuticals, Inc. | 31.88B |
| Anika Therapeutics, Inc. | 286.86M |
| Savara, Inc. | 1.147B |
| Vericel Corp. | 2.200B |
Market Cap Related Metrics
| Price to Book Value | 3.801 |
| Price | 0.3036 |
| Earnings Yield | -1.19K% |